Healthcare professionals

Welcome to the KOGENATE® Bayer site for healthcare professionals

KOGENATE® Bayer is a recombinant factor VIII treatment indicated for the treatment of haemophilia A.

In the early 1970s, Bayer HealthCare Pharmaceuticals introduced its first Factor VIII (FVIII) concentrate. Since then, we have dedicated ourselves to advancing the safety and efficacy of the factor VIII treatment we manufacture for patients with haemophilia A. We also strive to provide the bleeding disorders community with the tools, associated support programmes, and resources that can facilitate an improvement in the quality of life for those patients

Kogenate.co.uk is a unique resource of information on haemophilia, KOGENATE Bayer and factor VIII use. This area of the site which is dedicated to Healthcare Professional includes:

  • An image library
  • An online forum
  • Free access to the "Haemophilia" journal (via Wiley Publishing)
  • And resources for patients

Please click here to find out more

If you have any queries regarding KOGENATE® Bayer then please click here to contact Medical Information

Reconstitution kit

For more
information on the
reconstitution kit
> click here

Produced by Bayer. This website is intended for HealthCare professionals.
Date of preparation: December 2010 UK.PH.HN.KOG.2010.250.7.4